Review your center readiness for RLI & RLT
This site is intended for healthcare professionals outside of the United States (US) and the United Kingdom (UK).
This site is created and funded by Novartis.
If you are an HCP from one of the countries listed, you may select your country from the list to be redirected to your specific site.
Change country or language (Non-US)
-
International
-
https://rltcare.novartis.com/
Global -
https://rltcare.novartis.com/de-de/
Germany -
https://rltcare.novartis.com/es-es/
Spain -
https://www.rltcare.novartis.com/fr-fr/
France -
https://www.rltcare.novartis.com/pt-pt/
Portugal -
https://www.rltcare.novartis.com/br-pt/
Brazil -
https://www.rltcare.novartis.com/jp-ja/
Japan
Created in collaboration with industry experts, the questions below have been designed to help you understand your center’s current status and identify any areas where support or development may be beneficial. These questions should be viewed as a non-directive reference tool only, to help you reflect on your RLI and RLT readiness.
You can download these questionnaires here:
These questionnaires are intended to support consistent, transparent information-gathering and to serve as a reference for discussion, reflection, and documentation.
Items are prompts to consider, not required actions. The questionnaires are non-prescriptive and should not be interpreted as mandates, rules, or exhaustive checklists.
Users should adapt or skip questions based on context, organizational policies, and applicable laws and regulations.
No warranty is expressed or implied regarding completeness, accuracy, or fitness for a particular purpose; use is at the user’s discretion and risk.
Users are responsible for ensuring alignment with local policies, guidelines, regulations and laws. The content is for general informational purposes only and may not reflect all current best practices or regulations.
Created in collaboration with industry experts, the questions below have been designed to help you understand your center’s current status and identify any areas where support or development may be beneficial. These questions should be viewed as a non-directive reference tool only, to help you reflect on your RLI and RLT readiness.
You can download these questionnaires here:
These questionnaires are intended to support consistent, transparent information-gathering and to serve as a reference for discussion, reflection, and documentation.
Items are prompts to consider, not required actions. The questionnaires are non-prescriptive and should not be interpreted as mandates, rules, or exhaustive checklists.
Users should adapt or skip questions based on context, organizational policies, and applicable laws and regulations.
No warranty is expressed or implied regarding completeness, accuracy, or fitness for a particular purpose; use is at the user’s discretion and risk.
Users are responsible for ensuring alignment with local policies, guidelines, regulations and laws. The content is for general informational purposes only and may not reflect all current best practices or regulations.
RLI questionnaire
-
Infrastructure and Equipment
-
Training and Staff Competence
-
Regulatory Compliance and Safety
-
Radiation Protection
-
Quality Assurance and Safety Protocols
-
Equipment List
-
Patient Experience and Support
-
Data Management and Health Information
-
Financial and Insurance Considerations
-
Future Planning and Development
- What is the current infrastructure available for radiopharmaceutical handling and administration at your facility?
- Do you have a dedicated radiopharmacy laboratory? If so, can you describe its features and safety measures?
- What type of radiation shielding, and safety equipment do you have in place?
- Do you have a designated administration room for positron-based radiopharmaceuticals, and how is it equipped?
- How many PET/CT or SPECT/CT scanners are currently available in your facility, and what is their average age?
- How many radiopharmaceutical administration points can be used simultaneously in your facility?
- What is the level of training and experience of your staff with radiopharmaceuticals, especially with positron-based radiopharmaceuticals?
- Do you have a nuclear medicine physician and radiopharmacist on staff? Can you describe their qualifications?
- How do you ensure ongoing training and education for your staff regarding new Ga-68 radiopharmaceutical protocols and safety procedures?
- Do you have trained and licensed nurses or technologists available for the administration of radiopharmaceuticals?
- Do you have an expert medical physicist available on site to support dosimetry and advanced imaging protocols?
- Can your center perform patient-specific dosimetry studies when required?
- Are your procedures in line with local and national regulations for radiopharmaceuticals?
- Do you have the necessary licenses for storing and handling positron-based imaging radiopharmaceutical agents?
- How do you manage radiation safety and waste disposal in line with regulatory standards?
- Can your facility modify or expand existing licenses to accommodate new isotopes or increased storage/activity limits?
- What type of licenses are currently held at your institution?
- What is your experience and available equipment for radiation protection, specifically for positrons?
- What is your experience with handling Ge-68/Ga-68 generators?
- Can you describe the protocols you have in place for patient selection, dosing, and monitoring for positron-based radiopharmaceuticals?
- How do you manage patient preparation and follow-up care for positron-based radiopharmaceuticals?
- Please list the equipment you have available for the production and quality control of radiopharmaceuticals:
- Do you have appropriate maintenance and calibration programs for your equipment?
- How do you manage patient education and consent for RLI?
- What support services are available for patients undergoing RLI at your facility?
- How do you collect and manage data related to RLI treatments?
- Do you have a system for tracking patient outcomes and treatment efficacy?
- How do you handle the financial aspects of RLI, including insurance and reimbursement?
- What is the cost structure for RLI services at your facility?
- What are your plans for expanding or enhancing RLI services in the future?
- How do you stay updated with the latest developments and research in RLI?
RLT questionnaire
-
Facility and Infrastructure
-
Staff Training and Expertise
-
Regulatory Compliance and Licensing
-
Clinical Protocols and Patient Care
-
Equipment and Quality Control
-
Health System Integration and Service Provision
-
Patient Experience and Support
-
Data Management and Health Information
-
Financial and Insurance Considerations
-
Future Planning and Development
- What is the current infrastructure available for radiopharmaceutical handling and administration at your facility?
- Do you have a dedicated radiopharmacy laboratory? If so, can you describe its features and safety measures?
- What type of radiation shielding and safety equipment do you have in place?
- Is there a designated administration room for RLT, and how is it equipped?
- Does your facility treat RLT patients as in-patients, out-patients, or both?
- What is the capacity of your facility for in-patient RLT treatment?
- What is the average length of stay for in-patient RLT treatment in your facility?
- Is your infrastructure adapted to the handling of specific RLT isotopes, such as alpha-, beta or gamma-emitting radionuclides?
- What is the level of training and experience of your staff with radiopharmaceuticals, especially with RLT?
- Do you have a nuclear medicine physician and radiopharmacist on staff? Can you describe their qualifications?
- How do you ensure ongoing training and education for your staff regarding new RLT protocols and safety procedures?
- Do you have trained and licensed nurses/technologists available for RLT administration and patient monitoring?
- Are your procedures in line with the local and national regulations for radiopharmaceuticals?
- Do you have the necessary licenses for storing and handling therapeutic radiopharmaceuticals?
- How do you manage radiation safety and waste disposal in line with regulatory standards?
- Can you describe the protocols you have in place for patient selection, dosing, and monitoring for RLT?
- How do you manage patient preparation and follow-up care for RLT?
- Do you have protocols for emergency situations related to radiopharmaceutical administration?
- What equipment do you have for the preparation, administration, and monitoring of RLT?
- How do you ensure quality control and sterility of radiopharmaceuticals?
- Do you use infusion pumps or automatic injection systems for RLT administration?
- Do you have protocols in place for troubleshooting equipment issues and managing injection-related incidents (e.g., extravasation, contamination)?
- Are there designated waste collection and storage systems for RLT-specific radioactive waste?
- How is RLT integrated into your overall cancer care services?
- Do you collaborate with other departments or external partners for RLT services?
- What is the referral process for patients needing RLT at your facility?
- Are multidisciplinary tumor boards in place at your facility? If so, which ones regularly include RLT discussion?
- Is an RLT expert a regular participant in your institutional tumor boards?
- Are patients referred from external centers required to be reviewed by your institutional tumor board before receiving RLT?
- How do you manage patient education and consent for RLT?
- What support services are available for patients undergoing RLT at your facility?
- How do you collect and manage data related to RLT treatments?
- Do you have a system for tracking patient outcomes and treatment efficacy?
- How do you handle the financial aspects of RLT, including insurance and reimbursement?
- What is the cost structure for RLT services at your facility?
- What are your plans for expanding or enhancing RLT services in the future?
- How do you stay updated with the latest developments and research in RLT?
Learn from experts to prepare your center
Topics cover facility layout, radiation safety, imaging procedures, patient & drug management, and the importance of multi-disciplinary tumor board meetings.
Get in touch
Our dedicated RLT specialist teams aim to streamline care coordination and alleviate uncertainty, ensuring you and your patients feel confident and supported every step of the way.